NRx Pharma (NRXP): Rega marang dodolan

Tandha merek NRx Pharmaceuticals, Inc (NRXP)

NRx Pharmaceuticals is advancing psychopharmacology through partnerships with mental health centers, accelerating the patenting of software. The P/S ratio history reflects market valuation dynamics, where the current value is 27.80. However, test volatility and financial instability create risks. Simultaneously, NRx Pharmaceuticals is implementing software robots to digitize medical records to accelerate the time-to-market for its drugs.

NRXP (nrxpharma.com) riwayat Rasio rega marang pendapatan saka 16.11.2025 nganti 16.11.2026

NRx Pharmaceuticals (NRXP) - rincian metrik lan laporan keuangan

Analisis fundamental perusahaan:NRx Pharmaceuticals, Inc. - NRXP
Produk sing diprodhuksi NRx Pharmaceuticals, Inc

NRx Pharmaceuticals focuses on developing innovative therapies for severe depressive states. The P/S ratio measures market capitalization relative to annual sales volume, determining the cost of one dollar of revenue. This metric allows an investor to assess the efficiency of the company's monetization of clinical successes compared to industry peers. Analyzing the revenue multiple helps identify deviations of the asset's current value from its historical norms.